Targeting NF-κB in Waldenstrom macroglobulinemia

The nuclear factor-κB (NF-κB) path-way has been implicated in tumor B-cell survival, growth, and resistance to therapy. Because tumor cells overcome single-agent antitumor activity, we hypothesized that combination of agents that target differentially NF-κB pathway will induce significant cytotoxici...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Leleu, Xavier, Eeckhoute, Jérôme, Jia, Xiaoying, Roccaro, Aldo M., Moreau, Anne-Sophie, Farag, Mena, Sacco, Antonio, Ngo, Hai T., Runnels, Judith, Melhem, Molly R., Burwick, Nicolas, Azab, Abdelkareem, Azab, Feda, Hunter, Zachary, Hatjiharissi, Evdoxia, Carrasco, Daniel R., Treon, Steven P., Witzig, Thomas E., Hideshima, Teru, Brown, Myles, Anderson, Kenneth C., Ghobrial, Irene M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2008
Gaiak:
Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2384134/
https://ncbi.nlm.nih.gov/pubmed/18334673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-115170
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak